This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


1g7f

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:1g7f.gif|left|200px]]
+
{{Seed}}
 +
[[Image:1g7f.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1g7f| PDB=1g7f | SCENE= }}
{{STRUCTURE_1g7f| PDB=1g7f | SCENE= }}
-
'''HUMAN PTP1B CATALYTIC DOMAIN COMPLEXED WITH PNU177496'''
+
===HUMAN PTP1B CATALYTIC DOMAIN COMPLEXED WITH PNU177496===
-
==Overview==
+
<!--
-
Protein tyrosine phosphatase 1B (PTP1B) attenuates insulin signaling by catalyzing dephosphorylation of insulin receptors (IR) and is an attractive target of potential new drugs for treating the insulin resistance that is central to type II diabetes. Several analogues of cholecystokinin(26)(-)(33) (CCK-8) were found to be surprisingly potent inhibitors of PTP1B, and a common N-terminal tripeptide, N-acetyl-Asp-Tyr(SO(3)H)-Nle-, was shown to be necessary and sufficient for inhibition. This tripeptide was modified to reduce size and peptide character, and to replace the metabolically unstable sulfotyrosyl group. This led to the discovery of a novel phosphotyrosine bioisostere, 2-carboxymethoxybenzoic acid, and to analogues that were &gt;100-fold more potent than the CCK-8 analogues and &gt;10-fold selective for PTP1B over two other PTP enzymes (LAR and SHP-2), a dual specificity phosphatase (cdc25b), and a serine/threonine phosphatase (calcineurin). These inhibitors disrupted the binding of PTP1B to activated IR in vitro and prevented the loss of tyrosine kinase (IRTK) activity that accompanied PTP1B-catalyzed dephosphorylation of IR. Introduction of these poorly cell permeant inhibitors into insulin-treated cells by microinjection (oocytes) or by esterification to more lipophilic proinhibitors (3T3-L1 adipocytes and L6 myocytes) resulted in increased potency, but not efficacy, of insulin. In some instances, PTP1B inhibitors were insulin-mimetic, suggesting that in unstimulated cells PTP1B may suppress basal IRTK activity. X-ray crystallography of PTP1B-inhibitor complexes revealed that binding of an inhibitor incorporating phenyl-O-malonic acid as a phosphotyrosine bioisostere occurred with the mobile WPD loop in the open conformation, while a closely related inhibitor with a 2-carboxymethoxybenzoic acid bioisostere bound with the WPD loop closed, perhaps accounting for its superior potency. These CCK-derived peptidomimetic inhibitors of PTP1B represent a novel template for further development of potent, selective inhibitors, and their cell activity further justifies the selection of PTP1B as a therapeutic target.
+
The line below this paragraph, {{ABSTRACT_PUBMED_11341829}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 11341829 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_11341829}}
==About this Structure==
==About this Structure==
Line 29: Line 33:
[[Category: Inhibitor]]
[[Category: Inhibitor]]
[[Category: Tyrosine phosphatase]]
[[Category: Tyrosine phosphatase]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May 2 17:14:03 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 1 04:49:37 2008''

Revision as of 01:49, 1 July 2008

Image:1g7f.png

Template:STRUCTURE 1g7f

HUMAN PTP1B CATALYTIC DOMAIN COMPLEXED WITH PNU177496

Template:ABSTRACT PUBMED 11341829

About this Structure

1G7F is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Small molecule peptidomimetics containing a novel phosphotyrosine bioisostere inhibit protein tyrosine phosphatase 1B and augment insulin action., Bleasdale JE, Ogg D, Palazuk BJ, Jacob CS, Swanson ML, Wang XY, Thompson DP, Conradi RA, Mathews WR, Laborde AL, Stuchly CW, Heijbel A, Bergdahl K, Bannow CA, Smith CW, Svensson C, Liljebris C, Schostarez HJ, May PD, Stevens FC, Larsen SD, Biochemistry. 2001 May 15;40(19):5642-54. PMID:11341829

Page seeded by OCA on Tue Jul 1 04:49:37 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/1g7f"
Personal tools